Dexmedetomidine and MidazolamKetamine and Midazolam
Dexmedetomidine and Midazolam: Children will receive Dexamedetomedine and Midazolam
Ketamine and Midazolam: Children will receive Ketamine and Midazolam
Study summary
Fifty children undergoing heart catheterization without local anesthesia in the skin will be randomly divided into two groups.
Group DM (Dexmedetomidine + Midazolam) and Group KM (Ketamine + Midazolam)
Eligibility
Sex
ALL
Min age
2 Years
Max age
6 Years
Healthy volunteers
No
Inclusion Criteria:
* Scheduled for elective cardiac catheterization under general anesthesia.
Exclusion Criteria:
* neurological disorder, psychiatric disease, or current psychoactive medication.
* allergy.
* significant systemic comorbidities.
Primary outcome measure(s)
Emergence delirium — 30 minutes post-anesthesia Incidence of emergence delirium assessed using the Pediatric Anesthesia Emergence Delirium PAED scale. The scale consists of five behavioral items, each rated on a 5-point scale from 0 to 4(Eye contact, Purposefulness, Awareness, Restlessness, Inconsolability),Total scores range from 0 to 20.A PAED score ≥10 will be considered a clinically significant ED.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.